跳至主要内容
临床试验/NCT05763563
NCT05763563已完成不适用

Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年2月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Objective physical functioning and fitness - Follow-up

研究概览

简要总结

The purpose of the study is to evaluate an exercise program for individuals preparing for Chimeric Antigen Receptor (CAR) T-cell immunotherapy for hematological malignancies.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥65 years
  • •Lymphoma, leukemia, or myeloma with commercial FDA-approved CAR-T delivery planned for ≥4 weeks following enrollment
  • •Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • •Able to read and speak English fluently
  • •Capable of providing informed consent
  • •For optional, tele-supervised aerobic training procedure involving stationary bicycle delivery, participants must live within a 2-hour drive of Moffitt Cancer Center as determined via Google Maps.

排除标准

  • •Regular engagement in Resistance training (2x/week targeting all major muscle groups)
  • •Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q) and Patient-Reported Measurement Information System (PROMIS) screening questions
  • •Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV).
  • •Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT using body weight
  • •Numeric pain rating scale of ≥ 7 out of 10
  • •Myopathic or rheumatologic disease that impacts physical function
  • •Cognitive, visual, or auditory limitations that preclude safe engagement in remotely-supervised resistance training sessions or independent aerobic exercise (as determined by patients' treating oncologists and specified in clinic notes outlining disease history).

研究组 & 干预措施

Exercise prehabilitation

Experimental

Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo CAR-T therapy (Approximately 4-6 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.

干预措施: Optional Aerobic Exercise Procedure (Behavioral)

Exercise prehabilitation

Experimental

Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo CAR-T therapy (Approximately 4-6 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.

干预措施: Resistance Training (Behavioral)

Exercise prehabilitation

Experimental

Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo CAR-T therapy (Approximately 4-6 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.

干预措施: Aerobic Exercise (Behavioral)

Exercise prehabilitation

Experimental

Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo CAR-T therapy (Approximately 4-6 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.

干预措施: Optional In-Person Exercise Sessions (Radiation)

结局指标

主要结局

Objective physical functioning and fitness - Follow-up

时间窗: Up to 3 Months

Physical functioning and fitness will be assessed using the 30-second chair stand test,30-second arm curl test, and treadmill 6-minute walk test.

Objective physical functioning and fitness - Baseline

时间窗: At Baseline

Physical functioning and fitness will be assessed using the 30-second chair stand test,30-second arm curl test, and treadmill 6-minute walk test.

Participant Evaluation of Feasibility and Acceptability - Acceptability

时间窗: Up to 3 Months

Participants evaluation of feasibility and acceptability will be assessed with a questionnaire, adapted to fit the intervention. The questionnaire includes both Likert Scale and open-ended questions. An item-by-item basis and as average item score, with scores ≥4 ("agree" to "strongly agree") indicating acceptability. Open-ended responses will be analyzed qualitatively to inform intervention improvement.

Adherence - Feasibility

时间窗: Up to 3 Months

Adherence will be based on participants attending ≥ 70% of tele-RT sessions on average and performing ≥ 70% of prescribed moderate-intensity aerobic exercise per week

Participant Skeletal Muscle Index (SMI) - Baseline

时间窗: Baseline

Participants SMI will be measured using Tomovision SliceOMatic software and clinical, computerized tomography (CT) scans

Participant Self Reported Exercise - At 3 Months

时间窗: Up to 3 Months

Participant self-reported exercise will be measured using a modified Godin Leisure Time Exercise Questionnaire to assess both aerobic and resistance exercise

Participant Self Reported Exercise - At 6 Months

时间窗: Up to 6 Months

Participant self-reported exercise will be measured using a modified Godin Leisure Time Exercise Questionnaire to assess both aerobic and resistance exercise

Participant Self-Reported Musculoskeletal Injuries - Safety

时间窗: Up to 3 Months

The numerator of the safety variable will be the number of musculoskeletal injuries or adverse health events reported as "likely related" or "definitely related" the exercise programming and that caused at least some limitation of daily activity lasting more than 3 days. The denominator of the safety variable will be the number of exercise sessions performed by the participant (tele-resistance training plus aerobic exercise sessions lasting ≥10 minutes). The intervention will be considered safe if the rate of musculoskeletal injuries (i.e., muscle strains or pulls, sprains, exacerbated bone pain, fractures or breaks, or other adverse health events incurred during exercise sessions) is lower than the published metric of 11.9 injuries per 1000 sessions, as used as a benchmark in previous exercise oncology research

Participants Health-Related Quality of Life - Baseline

时间窗: Baseline

Participants health-related quality of life will be measured using the 12-item Medical Outcomes Study Short Form Survey

Percentage of Participants that Enroll and Consent - Enrollment Feasibility

时间窗: Up to 12 Months

Enrollment will be considered feasible if ≥60% of eligible and approached patients actually consent and enroll

Percentage of Participants that Complete Study Assessments - Retention Feasibility

时间窗: Up to 3 Months

Retention will be considered feasible if ≥70% of participants complete study measures

Participant Skeletal Muscle Index (SMI) - Follow-up

时间窗: After CAR-T Therapy, Up to 6 Months

Participants SMI will be measured using Tomovision SliceOMatic software and clinical, computerized tomography (CT) scans

Participant Self Reported Exercise - Baseline

时间窗: Baseline

Participant self-reported exercise will be measured using a modified Godin Leisure Time Exercise Questionnaire to assess both aerobic and resistance exercise

Participants Health-Related Quality of Life - At 3 Months

时间窗: Up to 3 Months

Participants health-related quality of life will be measured using the 12-item Medical Outcomes Study Short Form Survey

Participants Health-Related Quality of Life - At 6 Months

时间窗: Up to 6 Months

Participants health-related quality of life will be measured using the 12-item Medical Outcomes Study Short Form Survey

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验